Valuation: Cegedim

Market Cap 147M 169M 137M 126M 237M 16.1B 240M 1.61B 630M 8.04B 634M 621M 26.77B P/E 2026 *
7x
P/E 2027 * 5.34x
Enterprise Value 309M 356M 289M 265M 499M 33.9B 506M 3.38B 1.33B 16.94B 1.34B 1.31B 56.37B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 169M
-0.50%+13.05%-43.76%+24.21% 416B
+1.02%+9.66%-31.29%+39.21% 226B
-0.92%+5.53%-36.34%+4.66% 121B
+0.54%+4.51%-33.18%+16.69% 47.55B
-2.49%-1.26%-74.83%+160.25% 37.8B
-5.74%-9.06%-25.64%+20.33% 23.57B
-0.46%+5.31%-24.70%+69.83% 20.17B
-0.16%+2.50%-30.48%+6.20% 13.66B
-1.63%+3.05%-30.01%+85.92% 13.35B
Average -0.99%+1.93%-36.69%+47.48% 102.08B
Weighted average by Cap. -0.26%+11.35%-39.17%+32.05%

Financials

2026 *2027 *
Net sales 660M 760M 618M 565M 1.07B 72.4B 1.08B 7.23B 2.84B 36.17B 2.85B 2.79B 120B 684M 788M 641M 586M 1.11B 75.09B 1.12B 7.49B 2.94B 37.52B 2.96B 2.9B 125B
Net income 21.3M 24.54M 19.94M 18.24M 34.44M 2.34B 34.89M 233M 91.57M 1.17B 92.16M 90.15M 3.89B 28M 32.27M 26.22M 23.98M 45.28M 3.07B 45.87M 307M 120M 1.54B 121M 119M 5.11B
Net Debt 162M 187M 152M 139M 262M 17.8B 266M 1.78B 697M 8.89B 702M 686M 29.6B 134M 154M 125M 115M 216M 14.68B 219M 1.47B 575M 7.34B 579M 566M 24.42B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-